An early intelligent classification method and device for alzheimer's disease
By filtering, reducing dimensions, and removing drift from EEG signals, and combining this with the Riemann machine learning algorithm, a standard feature set for early Alzheimer's disease is extracted. This solves the problems of high cost or insufficient accuracy in existing technologies, and enables low-cost, high-precision early Alzheimer's disease diagnosis.
Patent Information
- Application Number
- CN202211166337.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2022-09-23
- Publication Date
- 2025-10-17
- Estimated Expiration
- 2042-09-23
AI Technical Summary
Existing methods for early screening of Alzheimer's disease, such as MRI imaging and cognitive scale assessments, suffer from high costs or insufficient diagnostic accuracy, and in particular, require a high level of education from the test subjects.
The Riemannian machine learning algorithm based on EEG signals is used to extract multi-frequency, cross-individual standard feature sets by filtering, dimensionality reduction and drift removal of EEG signals. The results are then classified using a hard voting mechanism to generate the final early Alzheimer's disease diagnosis.
It enables low-cost, high-precision early diagnosis of Alzheimer's disease, reduces the educational requirements for test subjects, and improves the accuracy of the test.